Bulletin
Investor Alert

New York Markets After Hours

Rigel Pharmaceuticals Inc.

NAS: RIGL

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207222917/composite

$

2.30

Change

+0.03 +1.31%

Volume

Volume 5,774

Sep 22, 2020, 4:53 p.m.

Real time quotes

/zigman2/quotes/207222917/composite

Today's close

$ 2.39

$ 2.27

Change

-0.12 -5.02%

Day low

Day high

$2.25

$2.41

Open
Open: 2.41

52 week low

52 week high

$1.23

$5.24

Open

Market cap

$403.74M

Average volume

9.74M

P/E ratio

N/A

Rev. per Employee

$281,703

EPS

-0.15

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rigl

MarketWatch News on RIGL

  1. Rigel Pharmaceuticals stock price target raised to $7 from $6 at J.P. Morgan

    7:26 a.m. Sept. 4, 2018

    - Tomi Kilgore

  2. Rigel Pharmaceuticals stock price target raised to $8 from $6 at BMO Capital

    9:26 a.m. April 18, 2018

    - Tomi Kilgore

  3. Rigel announces FDA approval, for real this time

    5:35 p.m. April 17, 2018

    - Jeremy C. Owens

  4. News that made Rigel stock pop was a mistake, Rigel says

    4:29 p.m. April 12, 2018

    - Jeremy C. Owens

  5. Rigel Pharmaceuticals CFO Ryan Maynard resigns after 7 1/2-years in the role

    8:35 a.m. Dec. 15, 2017

    - Tomi Kilgore

  6. Barron’s After Hours: Hess Jumps, Jabil Gains, Oracle Sinks

    9:31 p.m. Dec. 14, 2017

    - Barrons Blogs

  7. Charting the Market

    1:46 a.m. Oct. 7, 2017

    - Barron's Online

  8. Rigel Pharmaceuticals shares jump 9% premarket

    7:58 a.m. Oct. 3, 2017

    - Ciara Linnane

  9. Rigel Pharmaceuticals reports preliminary positive result in AIHA study

    7:33 a.m. Oct. 3, 2017

    - Ciara Linnane

  10. Charting the Market

    12:25 a.m. Oct. 22, 2016

    - Barron's Online

  11. Rigel Pharmaceuticals' stock on track to open at 3-mo. low

    8:53 a.m. Oct. 20, 2016

    - Tomi Kilgore

  12. Rigel Pharmaceuticals' stock plunges 34% premarket after drug trial disappoints

    8:53 a.m. Oct. 20, 2016

    - Tomi Kilgore

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rigl

Other News on RIGL

  1. Rigel Pharma Moves Forward With Midstage COVID-19 Study

    12:05 p.m. Sept. 17, 2020

    - 247WallSt.com

  2. SRNE, IMGN among premarket gainers

    8:29 a.m. Sept. 17, 2020

    - Seeking Alpha

  3. Rigel Pharma initiates fostamatinib mid-stage study for COVID-19

    7:52 a.m. Sept. 17, 2020

    - Seeking Alpha

  4. Rigel Pharmaceuticals: An Interesting Asset At Reasonable Price

    1:29 p.m. Sept. 15, 2020

    - Seeking Alpha

  5. Rigel Pharma gives new CCO option award

    8:36 a.m. Aug. 21, 2020

    - Seeking Alpha

  6. SQ, NVAX among premarket gainers

    8:25 a.m. Aug. 5, 2020

    - Seeking Alpha

  7. 10-Q: RIGEL PHARMACEUTICALS INC

    4:30 p.m. Aug. 4, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. Rigel (RIGL) Gets a Buy Rating from H.C. Wainwright

    5:31 a.m. July 22, 2020

    - SmarterAnalyst

  9. IPO Update: Annexon Proposes IPO Terms

    2:32 p.m. July 20, 2020

    - Seeking Alpha

  10. Seeking Alpha Catalyst Watch

    3:38 p.m. July 17, 2020

    - Seeking Alpha

  11. TCDA, NCLH among premarket losers

    8:16 a.m. July 16, 2020

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/rigl

Press Releases on RIGL

  1. Rigel to Present at Two Upcoming Investor Conferences

    7:30 a.m. Sept. 9, 2020

    - PR Newswire - PRF

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.